New Oral GLP-1 Receptor Agonist: AstraZeneca’s Type 2 Diabetes Breakthrough
Posted on June 13, 2026 by Amanda Mills
A GLP-1 receptor agonist is a medication that copies one of your gut hormones to take the edge off your appetite and bring blood sugar down. The GLP-1 receptor agonist started as a diabetes treatment and now is used for obesity too. In barely twenty years this class has flipped metabolic medicine on its head. […]